Flouvat B, Stheneur A, Massias P
Sem Hop. 1983 Dec 12;59(46):3187-90.
Kinetics of ketoprofen release in man from a sustained-release preparation (150 mg) and from capsules (3 X 50 mg) were studied comparatively in 10 healthy adults. Bioavailability of the slow-release preparation is similar to that of capsules : surfaces under the serum concentration curves and urinary elimination were found to be identical. In the sustained-release preparation the immediately available layer (75 mg) ensures achievement of maximal serum concentrations amounting to 59% of those obtained with capsules, after the same time interval. The slow-release layer (75 mg) produces higher serum concentrations from the third hour on, justifying administration of the formulation in two daily doses.
在10名健康成年人中对酮洛芬从缓释制剂(150毫克)和胶囊(3×50毫克)释放到人体中的动力学进行了比较研究。缓释制剂的生物利用度与胶囊相似:血清浓度曲线下面积和尿排泄量相同。在缓释制剂中,速释层(75毫克)可确保在相同时间间隔后达到最大血清浓度,相当于胶囊所获最大血清浓度的59%。缓释层(75毫克)从第三小时起产生更高的血清浓度,这证明该制剂每日分两次给药是合理的。